DOSE-DEPENDENT EFFECT OF STATINS ON THE PASSAGE OF CHD AMONG PATIENTS AFTER PRIMARY MYOCARDIAL INFARCTION


  • E.V. Sid State institution «Zaporizhia medical academy of post-graduate education ministry of health of Ukraine»
  • O.V. Soloviov State institution «Zaporizhia medical academy of post-graduate education ministry of health of Ukraine»
Keywords: CHD, myocardial infarction, statins, lipid-lowering therapy.

Abstract

DOSE-DEPENDENT EFFECT OF STATINS ON THE PASSAGE OF CHD AMONG PATIENTS AFTER PRIMARY MYOCARDIAL INFARCTION

References

1. Reed, G.W., Rossi, J.E., Cannon, C.P. Acute myocardial infarction // The Lancet. 2017; 389(10065): 197-210.

2. McNamara R.L., Kennedy K.F., Cohen D.J., et al. Predicting in-hospital mortality in patients with acute myocardial infarction // Journal of the American College of Cardiology. 2016; 68(6): 626-635.

3. Arnett D.K., Blumenthal R.S., Albert M.A., et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines // Journal of the American College of Cardiology. 2019; 74(10): e177-e232.

4. Alabas O.A., Jernberg T., Pujades-Rodriguez M., et al. Statistics on mortality ollowing acute myocardial infarction in 842 897 Europeans // Cardiovascular research. 2020; 116(1): 149-157.

5. Ibanez B., James S., Agewall S., et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) // European heart journal. 2018; 39(2): 119-177.

6. Wang W.T., Hellkamp A., Doll J.A., et al. Lipid testing and statin dosing after acute myocardial infarction // Journal of the American Heart Association. 2018; 7(3): e006460. doi: 10.1161/JAHA.117.006460.

7. Adhyaru B.B., Jacobson T.A. Safety and efficacy of statin therapy // Nature Reviews Cardiology. 2018; 15(12): 757-769.

8. Priti K., Agrawal A., Ranwa B.L. High versus low dose statin therapy in Indian patients with acute ST-segment elevation myocardial infarction undergoing thrombolysis // Indian Heart Journal. 2017; 69(4): 453-457.

9. Thygesen K., Alpert J.S., Jaffe A.S., et al. Third universal definition of myocardial infarction. ESC Committee for Practice Guidelines (CPG) // European heart journal. 2012; 33(20): 2551-67.

10. Thygesen K., Alpert J.S., Jaffe A.S., et al. Fourth Universal Definition of Myocardial Infarction (2018) // Global Heart. 2018; 13(4): 305-338.

11. Navarese E.P., Robinson J.G., Kowalewski M., et al. Association between baseline LDL-C level and total and cardi- ovascular mortality after LDL-C lowering: a systematic review and meta-analysis // JAMA. 2018; 319(15): 1566-1579.

12. Han X., Zhang Y., Yin L., et al. Statin in the treatment of patients with myocardial infarction: a meta-analysis // Medi- cine. 2018; 97(12): e0167. doi: 10.1097/MD.0000000000010167.

13. Gavazzoni M., Gorga E., Derosa G., et al. High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction // Drug Design, Development and Therapy. 2017; 11: 3425-3434. doi: 10.2147/ DDDT.S135173.

14. Hwang D., Kim H.K., Lee J.M., et al. Effects of statin intensity on clinical outcome in acute myocardial infarction pa- tients // Circulation Journal. 2018; CJ-17: 1221. doi: 10.1253/circj.CJ-17-1221

15. Catapano A.L., Graham I., De Backer G., et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias // European heart journal. 2016; 37(39): 2999-3058.
Published
2020-11-23
How to Cite
Sid, E., & Soloviov, O. (2020). DOSE-DEPENDENT EFFECT OF STATINS ON THE PASSAGE OF CHD AMONG PATIENTS AFTER PRIMARY MYOCARDIAL INFARCTION. Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 4(2), 7-12. https://doi.org/10.29256/v.04.02.2020.escbm02